LEADER 01555nam  2200421Ia 450 
001 9910698715903321
005 20090427142017.0
035   $a(CKB)5470000002396700
035   $a(OCoLC)319434504
035   $a(EXLCZ)995470000002396700
100   $a20090427d2008      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eE15 definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding catelgories
210  1$aSilver Spring, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evalutation and Research (CDER) ;$aRockville, MD :$cCenter for Biologics Evaluation and Research (CBER),$d[2008]
215   $ai, 7 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on Apr. 27, 2009).
300   $a"ICH".
300   $a"April 2008".
517   $aGuidance for industry 
606   $aGenomics
606   $aPharmacogenetics
606   $aPharmacogenomics
615  0$aGenomics.
615  0$aPharmacogenetics.
615  0$aPharmacogenomics.
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 12$aInternational Conference on Harmonisation.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698715903321
996   $aGuidance for industry$93434577
997   $aUNINA